Skip to content

CMTA Press Room

Official News From Charcot-Marie-Tooth Association

CMTA’s Press Room Is Where We Share News That Shapes Not Only the Future of CMT Research but Real Impact Today. From Funding Announcements to Trial Updates, This Is Where Progress Moves From Idea to Action.


  • Skilled Nonprofit Fundraiser Craig Zeltsar Brings Expertise to CMTA Board of Directors

    Nonprofit Fundraising Leader Craig Zeltsar Joins CMTA Board

    CMTA has welcomed Craig Zeltsar to its Board of Directors, bringing decades of nonprofit fundraising…

  • Shift Pharmaceuticals, Charcot-Marie-Tooth Association Partner on ASO Treatment for CMT1A

    CMTA, Shift Pharmaceuticals Partner on ASO Treatment for CMT1A

    CMTA has partnered with Shift Pharmaceuticals to evaluate an antisense oligonucleotide (ASO) for the treatment…

  • CMTA Kicks Off CMT Awareness Month 2022

    CMTA Launches CMT Awareness Month 2022

    CMTA kicks off CMT Awareness Month 2022 with a month-long series of educational and community-driven…

  • CMTA Welcomes Software Entrepreneur Jon Pastor to Board of Directors

    Software Entrepreneur Jon Pastor Joins CMTA Board

    CMTA has appointed software entrepreneur Jon Pastor to its Board of Directors, adding leadership experience…

  • CMTA Appoints Katherine Forsey, PhD, Chief Research Officer

    Katherine Forsey Appointed CMTA Chief Research Officer

    CMTA has appointed Katherine Forsey, PhD, as its first Chief Research Officer, reflecting the continued…

  • The Charcot-Marie-Tooth Association Earns a Perfect Rating From Charity Navigator

    CMTA Earns Perfect Charity Navigator Rating

    CMTA has earned a perfect score from Charity Navigator, receiving a four-star rating for financial…

  • CMTA Seed Money Draws NIH Support for Type 2 Gene Editing, Neurofilament Projects

    CMTA Seed Funding Leads to NIH Support for CMT2 Research

    CMTA seed funding has helped secure additional NIH support for two CMT type 2 research…

  • CMTA | STAR Awards $354,826 For Charcot-Marie-Tooth Clinical Trial

    CMTA-STAR Awards $354,826 for CMT Clinical Trial

    CMTA-STAR has awarded $354,826 to support a clinical trial evaluating L-serine in patients with Hereditary…

Want the latest CMT research, news, and community updates delivered to your inbox?

Sign up for CMTA’s eNews and stay connected with the latest in CMT and CMTA news and events.

Your Pathway Doesn’t End Here. Your Journey Continues.

Where to Next?